Peripheral Tolerance and Regulatory T Cells

Peripheral tolerance is the second line of self-restraint that controls self-reactive lymphocytes after they have left the thymus or bone marrow. Because central tolerance cannot purge every self-reactive cell, the periphery enforces tolerance actively, above all through regulatory T cells that suppress self-directed responses, and through cell-intrinsic brakes such as anergy and inhibitory checkpoint receptors.

Definition

Peripheral tolerance is the set of mechanisms operating outside the primary lymphoid organs that prevent mature self-reactive lymphocytes from causing harm, including dominant suppression by regulatory T cells, clonal anergy, and inhibitory checkpoint signalling.

Scope

The topic covers the principal mechanisms of peripheral tolerance, dominant suppression by regulatory T cells, clonal anergy, and inhibitory receptor pathways, and the master regulator that defines the regulatory T-cell lineage. It is a mechanistic, reference-level account of how self-reactivity is contained in the periphery and does not provide guidance on immunosuppressive or checkpoint-modulating therapy.

Core questions

• How do regulatory T cells suppress self-reactive responses that escape central tolerance?
• What master regulator defines the regulatory T-cell lineage?
• How do anergy and inhibitory receptors provide cell-intrinsic tolerance?
• How does the deliberate loosening of peripheral tolerance underlie checkpoint immunotherapy?

Key concepts

• Peripheral tolerance
• Regulatory T cells (Treg)
• Foxp3 transcription factor
• Dominant (suppressive) tolerance
• Clonal anergy
• Inhibitory checkpoint receptors (e.g., PD-1, CTLA-4)
• Self-reactivity containment

Key theories

Dominant tolerance by regulatory T cells

A dedicated population of suppressive T cells actively restrains self-reactive responses in the periphery, so that tolerance is enforced dominantly rather than depending only on the passive absence of self-reactive clones; their loss precipitates autoimmunity.

Foxp3 as the regulatory T-cell master regulator

The transcription factor Foxp3 specifies and programmes the regulatory T-cell lineage, providing a molecular definition of these suppressive cells and linking its deficiency to severe systemic autoimmunity.

Mechanisms

Self-reactive lymphocytes that escape central selection are restrained in the periphery by several overlapping mechanisms. Regulatory T cells, a suppressive lineage defined by the transcription factor Foxp3 identified by Hori and colleagues, actively dampen responses against self and were shown by Sakaguchi and colleagues to be required for self-tolerance, since their depletion provokes autoimmune disease. In parallel, T cells that encounter antigen without adequate co-stimulation can become anergic, and inhibitory receptors such as PD-1 deliver intrinsic braking signals that limit activation, a pathway reviewed by Sharpe and Pauken. Together these dominant and cell-intrinsic mechanisms contain the residual self-reactivity that central tolerance cannot eliminate.

Clinical relevance

Peripheral tolerance frames why its failure can lead to autoimmune disease and why its deliberate manipulation is therapeutically powerful: blocking inhibitory checkpoints releases anti-tumour T-cell responses in cancer immunotherapy, while regulatory T cells are studied for restoring tolerance in autoimmunity and transplantation. This entry presents those connections conceptually and is not a source of treatment recommendations.

Evidence & guidelines

The framework derives from experimental immunology, including the functional identification of regulatory T cells and of Foxp3, synthesised in major reviews rather than from clinical guidelines; claims trace to the cited primary studies and reviews.

History

The notion of dominant, suppressive tolerance was long contested until the functional identification of regulatory T cells marked by CD25 in 1995 placed it on firm ground, and the discovery that Foxp3 controls their development gave the lineage a molecular definition. In parallel, the characterisation of inhibitory checkpoint receptors reframed peripheral tolerance as a target that can be deliberately released, a shift that reshaped cancer immunotherapy.

Debates

How are tolerance and protective immunity balanced when checkpoints are released?

Loosening inhibitory pathways to enhance anti-tumour immunity can also break self-tolerance and provoke immune-related adverse effects, making the trade-off between restraint and protection a central question of the pathway's biology.

Key figures

• Shimon Sakaguchi
• Shohei Hori
• Arlene Sharpe
• Kristen Pauken

Seminal works

• sakaguchi-2008
• hori-2003
• sakaguchi-1995

Frequently asked questions

Why is peripheral tolerance needed if central tolerance already exists?

Central tolerance cannot purge every self-reactive cell, because not all self-antigens are displayed during development and affinity thresholds are imperfect, so peripheral mechanisms are needed to restrain the self-reactive cells that escape.

What are regulatory T cells?

They are a suppressive T-cell lineage, defined by the transcription factor Foxp3, that actively dampens immune responses against self; their loss leads to autoimmune disease, demonstrating that peripheral tolerance is actively enforced.